Precision Biosciences (DTIL) Net Equity Issued and Repurchased (2018 - 2026)
Precision Biosciences (DTIL) reported Net Equity Issued and Repurchased of $1,000 for fiscal Q4 2023 (quarter ended Dec 31, 2023).
Powered by 
Analysis
Precision Biosciences (DTIL) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
For FY2023 (ended Dec 31, 2023), Precision Biosciences posted Net Equity Issued and Repurchased of $31,000, down 99.9% from FY2022.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -28.9% (FY2018 to FY2023).
- By fiscal year, Net Equity Issued and Repurchased came in at $49.35 million in FY2022 (+93.7%), $25.48 million in FY2021, $689,000 in FY2020 (-99.5%) and $135.19 million in FY2019.
- The fiscal Q4 2023 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since fiscal Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.40 Bn | 1,112.99 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 634.88 Bn | 554.74 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 500.40 Bn | 473.51 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 356.05 Bn | 310.43 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 301.50 Bn | 265.49 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 264.72 Bn | 238.40 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.19 Bn | 169.39 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn | - |
| 10 | Precision Biosciences | 169.88 Mn | -179.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 83,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -20,000.00 |
| Jun 30, 2022 | 47.95 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 8.37 Mn |
| Sep 30, 2021 | 11.92 Mn |
| Jun 30, 2021 | 11.06 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 198,000.00 |
| Sep 30, 2020 | 532,000.00 |
| Jun 30, 2020 | 148,000.00 |
| Mar 31, 2020 | 451,000.00 |
API Access
Precision Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();